Heart Tissue Engineering is a cutting-edge interdisciplinary field that combines principles from engineering, biology, and medicine to develop methods for repairing or replacing damaged cardiac tissue. The goal is to create functional heart tissue in the laboratory that can be used for transplantation or to stimulate regeneration in the patient's own heart. This approach is particularly significant considering the limited regenerative capacity of the heart following injury, such as myocardial infarction. Researchers in heart tissue engineering focus on designing biomimetic scaffolds, often made of biocompatible materials, to support the growth and organization of cardiac cells. These scaffolds provide a structural framework for cells to adhere, proliferate, and differentiate into functional cardiac tissue. Cells used in heart tissue engineering include cardiomyocytes, which are responsible for contraction, and supportive cells like fibroblasts and endothelial cells. Bioreactors are employed to simulate physiological conditions, such as mechanical forces and electrical signals, promoting tissue maturation and functionality. Additionally, advances in stem cell technology contribute to a scalable and potentially personalized approach for generating cardiac cells for tissue engineering. Challenges in heart tissue engineering include achieving proper vascularization, ensuring electromechanical integration of engineered tissue with the recipient's heart, and addressing immune responses post-transplantation. While progress has been made in preclinical models, the translation of these strategies to clinical applications is an ongoing area of research. Heart tissue engineering holds promise for revolutionizing cardiac care by offering innovative solutions for heart repair and regeneration.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy